Abbott Laboratories;Novadel Pharma, Inc.;Novadel Pharma; Inc.
发明人:
Heit, Mark,Benitz, Antonio,Steadman, Dennis,Petrick, David
申请号：
AU2012200031
公开号：
AU2012200031B2
申请日:
2012.01.03
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2012200031B220130905.pdf#####ABSTRACT The invention includes compositions for transmucosal administration to an animal comprising at least one active agent and a pharmaceutically acceptable carrier. In one embodiment, the invention includes methods of treating or preventing a condition in an animal comprising transmucosally administering a composition comprising a therapeutically or prophylactically effective amount of an active agent and a pharmaceutically acceptable carrier.
